Skip to content

Felix Hammann

3 papers in the library · 153 citations · publishing 2017-2026

Papers

Sort Most recent Most cited

Explainable Artificial Intelligence (xAI) for 5-HT2A Receptor Binding Affinity of New Psychoactive Substances.

Molecules June 1, 2026 Verena Schöning, Katharina Elisabeth Grafinger, Daniel Pasin et al.

New psychoactive substances (NPS) are a heterogeneous group of recreational drugs that mimic the actions and psychoactive effects of existing pharmaceutical products or recreational drugs. As NPS can be highly potent, even exceeding their template compound's potency, there are frequent reports of non-fatal and fatal intoxications. One principal target for hallucinogenic and psychedelic drugs,...

DOI: 10.3390/molecules31111888 (opens in new tab) Full text (opens in new tab) 5-ht2a Nps Binding affinity Classification model +2

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects

Clinical Pharmacokinetics February 14, 2017 Patrick C. Dolder, Yasmin Schmid, Andrea E. Steuer et al. 134 citations

BACKGROUND AND OBJECTIVE: Lysergic acid diethylamide (LSD) is used recreationally and in clinical research. The aim of the present study was to characterize the pharmacokinetics and exposure-response relationship of oral LSD. METHODS: We analyzed pharmacokinetic data from two published placebo-controlled, double-blind, cross-over studies using oral administration of LSD 100 and 200 µg in 24 and...

Mistaking 2C-P for 2C-B: What a Difference a Letter Makes.

Journal of Analytical Toxicology 2017 Adrian Stoller, Patrick C. Dolder, Michael Bodmer et al. 19 citations

2,5-Dimethoxy-4(n)-propylphenethylamine (2C-P) is a synthetic phenethylamine derivative belonging to the large family of the so-called 2C drugs. These compounds can differ significantly in receptor affinity, potency and duration of action, and an important structural difference is the ligand in the 4 position of the phenyl ring, such as propyl in 2C-P or bromine in...

DOI: 10.1093/jat/bkw108 (opens in new tab) Full text (opens in new tab) Chemical structure variation Drug potency Synthetic drugs Adverse drug effects